
Clinician-Scientist: paeds, publichealth, #globalhealth, tropical medicine. Let’s @controlscabies #BeatNTDs & #EndRHD. @RCHMelbourne @MCRI_for_kids @UniMelbMDHS
Melbourne, Victoria
Joined February 2018
- Tweets744
- Following334
- Followers515
- Likes2K
Pinned Tweet
Thrilled and delighted to be a part of the GOAL trial team – published in @NEJM this week.
nejm.org/doi/full/10.1056/NE…
What is the GOAL trial and what does it mean? A thread.
1/🧵
Daniel Engelman retweeted
Please join us for the Scabies Control Meetings 2023 (COR-NTD Research Links) in two weeks!
Meeting 1 Euro/Africa
Wed 15 November 9am – 11am GMT
Register: bit.ly/3SjRuxx
Meeting 2 Asia/Pacific/PAHO
Tues 21 November 9am - 11am AEDT
Register: bit.ly/46UTtgc
Daniel Engelman retweeted
Our last AAMRI Rising Star Finalist whose work we're excited to share is Prof Andrew Steer from @MCRI_for_kids. Andrew is a paediatric infectious diseases physician, his research has measurably improved the lives of people suffering from tropical diseases, particularly scabies.
Daniel Engelman retweeted
Acute rheumatic fever (ARF) & rheumatic heart disease (AHD) are serious conditions most often occurring in children from priority groups. Today they become notifiable conditions in Vic. This important step will support our public health response & understanding of these diseases.
From today, acute rheumatic fever (ARF) & rheumatic heart disease (RHD) are routine notifiable conditions in Victoria.
Visit the Department of Health website for more information: go.vic.gov.au/3QhKz70
Hugely pleased that after many years of work, #RheumaticFever and #RHD are now notifiable in Victoria. Important step toward control of these diseases. @RCHMelbourne @MCRI_for_kids #EndRHD
From today, acute rheumatic fever (ARF) & rheumatic heart disease (RHD) are routine notifiable conditions in Victoria.
Visit the Department of Health website for more information: go.vic.gov.au/3QhKz70
Daniel Engelman retweeted
@ControlScabies steering committee diligently gather on final day of @wcd2023sg with international participation via zoom. Each this space you derms- there is work to be done #importantstuff #beatskinntds @IFDerm @glodermalliance
Daniel Engelman retweeted
Beaton et al. describe echocardiographic and socioeconomic risk factors to refine the risk associated with latent rheumatic heart disease in children #Researchletter @MariaCarmoNune1 @emmyrov @dan_engelman @drmirabel #AHAJournals ahajournals.org/doi/10.1161/…
Daniel Engelman retweeted
Congratulations to Professor Trevor Duke on being awarded the Royal Children’s Hospital Chair’s Medal this year. I recommend you listen to his acceptance speech for a display of humility, wisdom and kindness: youtu.be/vSiEnGWGZuA
Our new paper @JPCHonline - #RheumaticFever and #RHD in kids and adolescents in Victoria, Australia. We highlight major inequity, failures of secondary prevention, severe disease and the need for public health control to #EndRHD
doi.org/10.1111/jpc.16305
Daniel Engelman retweeted
Only a few days to go until the IACS Control Meeting 2 (COR-NTD Research Links)
Access Meeting 2 Agenda here: bit.ly/3NW3XTY
Tues 15 Nov 2022 9am - 11am GMT
REGISTER: bit.ly/3CGcvZS
The annual IACS #Scabies Control webinars are on this Monday/Tuesday and next. Lots of great new content, research and control presentations. Co-presented with @COR_NTD this year. Free to register - details below. #TropMed22 #BeatNTDs @glodermalliance
ONE DAY TO GO until the IACS Control Meeting 1 (COR-NTD Research Links)
Access the Meeting 1 Agenda here: bit.ly/3UxyWIi
Register here for Meeting 1 if you haven't already: bit.ly/3CArkxf
Daniel Engelman retweeted
A new study to improve access to quality & culturally safe care for Rheumatic Heart Disease (RHD) is underway in Aboriginal and Torres Strait Islander communities.
Read more about this work, supported by a #MRFF grant, in this Healthy Tomorrow article: bit.ly/3SMG81H
Daniel Engelman retweeted
Less than one week to go! IACS Control Webinars (COR-NTD Research Links) 2022
Register to attend our first meeting on 7 Nov 2022 11pm - 1am GMT (10:00am -12:00pm Australian EDT)
DON'T MISS OUT, REGISTER HERE: bit.ly/3CArkxf
Daniel Engelman retweeted
TWO WEEKS TO GO! IACS Control Webinars 2022 (COR-NTD Research Links)
Register to attend the virtual meetings below,
Meeting 1 Tues 8 Nov 2022 11pm - 1am GMT
REGISTER: bit.ly/3CArkxf
Meeting 2 Tues 15 Nov 2022 9am - 11am GMT
REGISTER: bit.ly/3CGcvZS
Daniel Engelman retweeted
We are excited to announce the 2nd IACS/RSTMH Early Career Grant Awardee for 2022!
Dr Sarika Palepu will receive funding for her project on ‘the impact of training front-line workers in improving the yield of scabies diagnosis among children in a rural community of West Bengal’
Daniel Engelman retweeted
REGISTER NOW! IACS Annual Scabies Control Webinars 2022 (COR-NTD Research Links)
Meeting 1: Tues 8 Nov 2022 11pm - 1am GMT
Register here: bit.ly/3CArkxf
Meeting 2: Tues 15 Nov 2022 9am - 11am GMT
Register here: bit.ly/3CGcvZS
Daniel Engelman retweeted
By joining forces with the best minds, we know we can achieve our goal of developing a safe & effective #StrepA vaccine for the prevention of pharyngitis to stop post-Strep A immune mediated diseases such as acute rheumatic fever & rheumatic heart disease #RHD.
#WorldHeartDay ❤️
Such a great achievement - World Scabies Program and Fiji MOH launch MDA for #scabies in #Fiji - integrated with LF in Vanua Levu.
#BeatNTDs @ControlScabies
This Post is from a suspended account. Learn more
Daniel Engelman retweeted
Glad the 2nd mass drug administration for lymphatic filariasis and scabies elimination has launched in the Northern Division through the work of the @MOHFiji Northern Health team, #FijiCDC LF team and World Scabies Program @MCRI_for_kids supported by @jica_direct_en @WHOWPRO
This Post is from a suspended account. Learn more
Daniel Engelman retweeted
For all Clinicians and researchers working with StrepA, this great Series of surveillance papers released in #OFID today @telethonkids @WCVID @UWAresearch @ASIDANZ @ASIDcrn @anzpid @WSPID academic.oup.com/ofid/issue/…
























